Companies Dominating the Diabetes Devices Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- ARKRAY, Inc.
- Bayer AG
- Lifescan, Inc.
- B. Braun Melsungen AG
- Dexcom, Inc.
- Insulet Corporation
- Ypsomed AG
- Sanofi
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Diabetes Devices Market in 2025 is estimated at USD 35.56 billion.
The global market size surpassed USD 33.55 billion in 2024 and is projected to witness a CAGR of over 7.5%, crossing USD 85.9 billion revenue by 2037.
North America is forecast to generate largest share by 2037, owing to increase in the prevalence of diabetes cases, rising healthcare expenditure, and the growing presence of dominant players in insulin syringe manufacturers.
The major players in the market include Medtronic plc, Abbott Laboratories, ARKRAY, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.
